Orifarm Manufacturing Hobro A/S

CVR 41059044 · Public limited company (A/S) · Active · Low risk

Orifarm Manufacturing Hobro A/S is a Public limited company (A/S), founded on , based in Hobro. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 46.0m and a net result of DKK 3.8m.

Bankruptcy risk for Orifarm Manufacturing Hobro A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 33% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Reporting classReporting class C, mellemstor virksomhed · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
41059044
Status
Active
Company type
Public limited company (A/S)
Founded
(6 years)
Address
Apotekerstien 9
9500 Hobro
Municipality
Mariagerfjord
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 400k
Auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio38.8%
Current ratio57%
Moves (last 2 years)0
CEO changes in total11
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 57.0mDKK 58.6mDKK 59.7m
Net profitDKK 3.8mDKK 2.9mDKK 5.0m
EquityDKK 46.0mDKK 48.8mDKK 45.9m
Total assetsDKK 118.4mDKK 107.7mDKK 125.0m
Short-term debtDKK 69.9mDKK 56.2m–
Tax owedDKK 1.1mDKK 329k–
Avg. employees6062–

Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025148
1 Jan 2024 – 31 Dec 2024163
1 Jan 2023 – 31 Dec 2023158
1 Jan 2022 – 31 Dec 2022158
1 Jan 2020 – 31 Mar 2021154

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPeter Andreas Stakemann
CEOMarianne Damgaard-Sørensen
CEOGhita Astrup
CEOJacob Lucassen
CEOErik Sandberg
CEOAllan Dinesen
BoardMads Fink EriksenCurrent
BoardHans Carl Bøgh-SørensenCurrent
BoardNicki Lund KristensenCurrent
BoardJacob Lucassen
BoardErik Sandberg
BoardAllan Dinesen
BoardHans Carl Bøgh-Sørensen
BoardThomas Hørslev Hedegaard
Owner (100%)ORIFARM GROUP A/SCurrent
Owner (100%)ApS KBURS 17 NR. 6919
Owner (100%)Takeda Pharmaceuticals International AG
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorKPMG P/S
FounderApS KBURS 17 NR. 6919Current

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Marianne Damgaard-Sørensen – 1 other companies

Ghita Astrup – 18 other companies, of which 6 bankrupt

Jacob Lucassen – 13 other companies

Erik Sandberg – 30 other companies

Address history (3 moves)

Apotekerstien 9, 9500 Hobro
Energivej 15, 5260 Odense S
c/o Takeda Pharma A/S, Delta Park 45, 2665 Vallensbæk Strand
Kronprinsessegade 18, 1306 København K

Former names

Orifarm Manufacturing Hobro A/S – now
Orifarm Manufacturing Hobro ApS –
Dalmore Invest (Denmark) ApS –
ApS STM nr. 6418 –

Questions and answers about Orifarm Manufacturing Hobro A/S

Has Orifarm Manufacturing Hobro A/S gone bankrupt?

No, Orifarm Manufacturing Hobro A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Orifarm Manufacturing Hobro A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of Orifarm Manufacturing Hobro A/S?

Orifarm Manufacturing Hobro A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Orifarm Manufacturing Hobro A/S founded?

Orifarm Manufacturing Hobro A/S was founded on 1 January 2020.

What is the equity of Orifarm Manufacturing Hobro A/S?

Equity was DKK 46.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.